Cargando…
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs
An objective of phase I dose‐finding trials is to find the maximum tolerated dose; the dose with a particular risk of toxicity. Frequently, this risk is assessed across the first cycle of therapy. However, in oncology, a course of treatment frequently consists of multiple cycles of therapy. In many...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092569/ https://www.ncbi.nlm.nih.gov/pubmed/36250912 http://dx.doi.org/10.1002/sim.9593 |